Lipid and Lab Reporting

• Nonfasting samples can be used to measure total cholesterol (TC), HDL-C and HDL-C.

• TG can be measured in a nonfasting state, but reference intervals in a nonfasting form must be established for the same in larger populations.

• For patients, laboratories and clinicians, nonfasting lipid profiles represent a simplification without negative implications for CVD prevention for prognostic, diagnostic and therapeutic options.

• The burden of ASCVD in India is alarmingly high and is a cause of concern.

• In patients with established ASCVD, treatment decisions pertaining to the use of preventive CV therapies are relatively straightforward as all patients require aggressive risk reduction.

• However, in patients who do not have pre-existing ASCVD, i.e., those requiring primary prevention of ASCVD, wide heterogeneity in the likelihood of developing ASCVD necessitates some form of risk stratification.

• Now is the time to formulate a lipid profile report that gives personalized risk stratification to the patients, as the knowledge of the anticipated ASCVD risk may help improve patients’ health-related behaviors and compliance with the interventions.